Hepatitis C virus (HCV) causes both acute and chronic infection. Acute HCV infection is usually asymptomatic, and is only very rarely associated with life-threatening disease. The incubation period for hepatitis C is 2 weeks to 6 months. Following initial infection, approximately 80% of people do not exhibit any symptoms. Those who are acutely symptomatic may exhibit fever, fatigue, joint pain and jaundice (yellowing of skin and the whites of the eyes). Causes Hepatitis C caused due to contact with contaminated blood or needles used to inject illegal drugs or draw tattoos. Sometimes you don't get any symptoms, or just mild ones. But in some cases hepatitis C leads to cirrhosis, a risky scarring of your liver.
HCV infection is diagnosed in 2 steps: Screening for anti-HCV antibodies with a serological test identifies people who have been infected with the virus. If the test is positive for anti-HCV antibodies, a nucleic acid test for HCV RNA is needed to confirm chronic HCV infection .Hepatitis C does not always require treatment as the immune response in some people will clear the infection, and some people with chronic infection do not develop liver damage. When treatment is necessary, the goal of hepatitis C treatment is cure.
Each of the hepatitis viruses causes similar liver damage. The inflammatory process is activated throughout the whole liver, and hepatocytes are destroyed by cytotoxic cytokines and natural killer cells, both parts of the inflammatory process. Cellular necrosis takes place. If inflammation affects the periportal areas, cholestasis, or the interruption of the flow of bile takes place.
statistics: There were a total of 2,758 laboratory reports of hepatitis C reported to the PHE between April and June 2015. There was a 2.6% increase in the number of reported cases compared to the first quarter of 2015 (n=2,689), and a 2.5% increase on the same quarter in 2014 (n=2,690). Age-group and sex were well reported (>98% complete). Where known males accounted for 68.7% of reports (1,876/2,732), which is consistent with previous quarters. Adults aged 25-44 years accounted for 49.9% of the total number of hepatitis C reports.